newsfilter
← Latest News
Earnings Call Transcripts·

MBRX_Annamycin vs. Current Anthracyclines_07.06.26 - JTC TEAM

Well, that's where we believe anamycin's improved safety profile really stands out. Anamycin is designed to be non-cardiotoxic, and the data to date, reviewed independently, showed no evidence of cardiotoxicity. And that